OR-RADISYS
17.10.2022 14:01:40 CEST | Business Wire | Press release
Radisys® Corporation and Telefónica S.A. today announced that Telefónica is disaggregating its broadband network with Radisys’ Connect Open Broadband portfolio to achieve greater network flexibility and programmability, to reduce the risk associated with supply chain shortages, and to make it easier to introduce new network solutions. Radisys’ Connect Open Broadband comes with hardware and software components, including white-box Combo-PON OLTs, the Connect Broadband Access Controller (CBAC), and the Radisys Management System (RMS) software. After extensive testing of Radisys’ cloud-native disaggregated broadband solution in the lab, Telefónica and Radisys have reached an agreement to deploy the technology in a live commercial network supporting residential and enterprise customers in 2023.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221017005146/en/
Addressing supply chain challenges head-on
Communications service providers (CSPs) are seeking to disaggregate their networks, de-coupling hardware and software components and selecting best-of-breed solutions from a multi-vendor ecosystem, rather than be tied to a proprietary supplier. The current global supply chain challenges make disaggregated network elements more important than ever. By choosing to disaggregate its network with Radisys’ Connect Open Broadband, Telefónica is able to mix and match components from multiple vendors and multiple supply chains which helps lower total cost of ownership while also mitigating supply chain risk associated with a proprietary solution.
Increasing flexibility and programmability
Telefónica is transitioning from legacy chassis-based OLT equipment to new solutions, where Radisys’ white-box OLTs with software-defined networking control to advance its telco cloud capabilities and achieve greater efficiency and automation. This increased programmability allows Telefónica to leverage automation and Artificial Intelligence/Machine Learning in its network to accelerate service innovation and new service introduction. In addition, Radisys’ hardware and software components easily integrate with Telefónica’s OSS/BSS, resulting in increased operational simplicity. It also supports zero-touch provisioning and greater programmability with SDN control.
Moving towards convergence
Radisys’ open-standards-based Combo-PON OLTs support G-PON and XGS-PON within the same PON port of the OLT, allowing Telefónica to seamlessly migrate subscribers to XGS-PON when needed and to scale its network, delivering broadband and ultra-broadband connectivity. Radisys’ Connect Open Broadband portfolio also supports Telefónica’s move towards network convergence, allowing Telefónica to readily adopt new business models and offer new services on one network.
Tapping into a cloud-native solution
Radisys’ Connect Open Broadband is already cloud-native, giving Telefónica the ability to migrate network control and management functions to the cloud, reducing its total cost of ownership while achieving cost-efficient network growth. Radisys’ CBAC open software facilitates faster product innovation cycles, increased automation, and deeper network visibility. Its microservices architecture and cloud-native design allow Telefónica to enable on-demand scaling and deployment agility and simplify network operations with end-to-end orchestration for a seamless customer experience. The Radisys Management System moves central office functions to the cloud, and it integrates seamlessly with existing OSS/BSS. It provides Telefónica with a single Web GUI for service management, subscriber management, device management, performance metrics, and more.
“We’ve been working closely with Radisys over the last few years to prove out that a disaggregated broadband network can meet the performance requirements of millions of subscribers, and we are confident in the Radisys solution,” said Daniel Cortes Olmeda, senior manager for Fixed Access, Telefónica S.A. “Telefónica partners with Radisys for deploying a new disaggregated architecture that will enable us to accelerate time-to-market and innovation while minimizing risks associated with supply chain challenges, enlarging the vendor map and guaranteeing business continuity.”
“Telefónica is an early pioneer in disaggregating its broadband network, while our open and disaggregated Connect Open Broadband solution is carrier-grade and ready for commercial deployment in the wider market,” said Harris Razak, head of Radisys’ Broadband Access Business. “We are working with Telefónica to prove out the real-world benefits of a disaggregated network in both urban and rural environments. Our solution offers flexibility and scalability for all fixed broadband scenarios. By selecting Connect Open Broadband, Telefónica has shown confidence in our solution for live commercial deployments.”
About Radisys
Radisys, a global leader in open telecom solutions, enables service providers to drive disruption with new open architecture business models. Radisys’ innovative disaggregated and virtualized enabling technology solutions leverage open reference architectures and standards, combined with open software and hardware to power business transformation for the telecom industry, while its world-class services organization delivers systems integration expertise necessary to solve communications and content providers’ complex deployment challenges. For more information, visit www.Radisys.com.
About Telefónica
Telefónica is one the largest telecommunications service providers in the world. The company offers fixed and mobile connectivity as well as a wide range of digital services for residential and business customers. With more than 384 million customers, Telefónica operates in Europe and Latin America. Telefónica is a 100% listed company and its shares are traded on the Spanish Stock Market and on those in New York and Lima.
Radisys® is a registered trademark of Radisys. All other trademarks are the property of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221017005146/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom